Atorvastatin/Fenofibrate 40/100 mg Fixed-Dose Combination Tablet (LCP-AtorFen 40/100 mg) Offers Improved Efficacy Over 40 mg Atorvastatin and Higher Dose 145 mg Fenofibrate in Patients with Dyslipidemia

被引：0
|
作者：
Davidson, Michael H. [1 ]
Rooney, Michael [1 ]
Drucker, Joan [1 ]
Griffin, H. E. [2 ]
Beckert, Michael [3 ]
机构：
[1] Fladiant Rsch Inc, Chicago, IL USA
[2] LifeCycle Pharma Inc, New York, NY USA
[3] LifeCycle Pharma AS, Horsholm, Denmark
来源：
CIRCULATION | 2008年 / 118卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S1139 / S1139
页数：1
相关论文
共 29 条
  • [21] Efficacy and Safety of a Fixed-Dose Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg in the Treatment of Patients with Vestibular Vertigo: An Individual Patient Data Meta-Analysis of Randomised, Double-Blind, Controlled Clinical Trials
    Scholtz, Arne W.
    Waldfahrer, Frank
    Hampel, Regina
    Weisshaar, Gerhard
    CLINICAL DRUG INVESTIGATION, 2022, 42 (09) : 705 - 720
  • [22] Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension:: Pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials
    Lacourcière, Y
    Neutel, JM
    Schumacher, H
    CLINICAL THERAPEUTICS, 2005, 27 (11) : 1795 - 1805
  • [23] A single-dose, randomized, open-label, two-period crossover bioequivalence study of a fixed-dose pediatric combination of lamivudine 40-mg, nevirapine 70-mg, and stavudine 10-mg tablet for oral suspension with individual liquid formulations in healthy adult male volunteers
    Monif, Tausif
    Thudi, Nageshwar Rao
    Tippabhotla, Sudhakar Koundinya
    Khuroo, Arshad
    Marwah, Amit
    Shrivastav, Vikesh Kumar
    Tandon, Monika
    Raghuvanshi, Rajeev
    Biswal, Shibadas
    CLINICAL THERAPEUTICS, 2007, 29 (12) : 2677 - 2684
  • [24] Fixed-Dose Combination Gel of Adapalene and Benzoyl Peroxide plus Doxycycline 100 mg versus Oral Isotretinoin for the Treatment of Severe Acne: Efficacy and Cost Analysis
    Penna, Pete
    Meckfessel, Matthew H.
    Preston, Norman
    AMERICAN HEALTH AND DRUG BENEFITS, 2014, 7 (01): : 37 - 44
  • [25] Efficacy and Safety of Subantimicrobial Dose, Modified-Release Doxycycline 40 mg Versus Doxycycline 100 mg Versus Placebo for the treatment of Inflammatory Lesions in Moderate and Severe Acne: A Randomized, Double-Blinded, Controlled Study
    Moore, Angela
    Ling, Mark
    Bucko, Alicia
    Manna, Vasant
    Rueda, Marie-Jose
    JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (06) : 581 - 586
  • [26] A randomized, double-blind, active-controlled trial assessing the efficacy and safety of a fixed-dose combination (FDC) of MEtformin hydrochloride 1000 mg ER, SItagliptin phosphate 100 mg, and DApagliflozin propanediol 10 mg in Indian adults with type 2 diabetes: The MESIDA trial
    Awadhesh Kumar Singh
    Rakesh Sahay
    Navneet Gil
    Sudhir Tripathi
    Vipul Khandelwal
    Indraneel Basu
    Jayashree Shembalkar
    Manoj Kumar Srivastava
    Girish Bhatia
    Vaishali Pathak
    Amol Dange
    Mayura Chaudhri
    Arindam Naskar
    Ashish Mondal
    Pawan Gangwal
    Surendra Kumar
    Deepak Kumar
    Yandrapati gnana sundara Raju
    Sanket Sorate
    Onkar Gavli
    Sunita Kumbalkar
    Deepak Varade
    Harshal Chaudhari
    Durga Prasad
    Manoj Patil
    Nikhil Bhagwat
    Rohit Agarwal
    Arun Pandey
    Soumya Ghosh
    Shubhashree Patil
    Vishal Kini
    Akhilesh Sharma
    Mayur Mayabhate
    Roshan Pawar
    Aashish Rajput
    Vinakaya Shahavi
    International Journal of Diabetes in Developing Countries, 2024, 44 : 67 - 76
  • [27] A randomized, double-blind, active-controlled trial assessing the efficacy and safety of a fixed-dose combination (FDC) of MEtformin hydrochloride 1000 mg ER, SItagliptin phosphate 100 mg, and DApagliflozin propanediol 10 mg in Indian adults with type 2 diabetes: The MESIDA trial
    Singh, Awadhesh Kumar
    Sahay, Rakesh
    Gil, Navneet
    Tripathi, Sudhir
    Khandelwal, Vipul
    Basu, Indraneel
    Shembalkar, Jayashree
    Srivastava, Manoj Kumar
    Bhatia, Girish
    Pathak, Vaishali
    Dange, Amol
    Chaudhri, Mayura
    Naskar, Arindam
    Mondal, Ashish
    Gangwal, Pawan
    Kumar, Surendra
    Kumar, Deepak
    Raju, Yandrapati Gnana Sundara
    Sorate, Sanket
    Gavli, Onkar
    Kumbalkar, Sunita
    Varade, Deepak
    Chaudhari, Harshal
    Prasad, Durga
    Patil, Manoj
    Bhagwat, Nikhil
    Agarwal, Rohit
    Pandey, Arun
    Ghosh, Soumya
    Patil, Shubhashree
    Kini, Vishal
    Sharma, Akhilesh
    Mayabhate, Mayur
    Pawar, Roshan
    Rajput, Aashish
    Shahavi, Vinakaya
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2024, 44 (01) : 67 - 76
  • [28] A randomized, placebo- and active-controlled, multi-country, multi-center parallel group trial to evaluate the efficacy and safety of a fixed-dose combination of 400 mg ibuprofen and 100 mg caffeine compared with ibuprofen 400 mg and placebo in patients with acute lower back or neck pain
    Predel, Hans-Georg
    Ebel-Bitoun, Caty
    Lange, Robert
    Weiser, Thomas
    JOURNAL OF PAIN RESEARCH, 2019, 12 : 2771 - 2783
  • [29] Efficacy and safety of once-daily extended-release dexmethylphenidate 30 and 40 mg in adults with ADHD: A double-blind, fixed-dose, placebo-controlled, randomized study
    Adler, L. A.
    Spencer, T.
    Wang, J.
    Pestreich, L.
    Muniz, R.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S229 - S229
123